Crusted and Eroded Plaques in Metastatic Lung Cancer
Author Information
Author(s): Wang Robin, Zahirsha Zisansha, Zelman Brandon, Speiser Jodi, Dahiya Madhu, Eilers David
Primary Institution: Loyola University Medical Center
Hypothesis
What is the diagnosis for a patient with a painful rash receiving atezolizumab therapy?
Conclusion
The patient was diagnosed with immune checkpoint inhibitor-induced bullous pemphigoid triggered by atezolizumab.
Supporting Evidence
- The patient initially developed bullae which subsequently led to the eroded plaques seen on physical exam.
- Histopathology demonstrates subepidermal blistering and direct immunofluorescence shows linear C3 and IgG deposition along the basement membrane.
Takeaway
A man with lung cancer developed painful skin plaques after starting a new cancer treatment, which turned out to be a side effect of the medication.
Methodology
The case involved a patient with a history of lung cancer and treatment with atezolizumab, who presented with a rash that was examined and diagnosed based on clinical and histopathological findings.
Participant Demographics
A 72-year-old man with a history of hypertension and monoclonal gammopathy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website